Data as of 10:04am ET
| +0.28 / +0.44%|
The 7 analysts offering 12-month price forecasts for Ligand Pharmaceuticals Inc have a median target of 92.00, with a high estimate of 98.00 and a low estimate of 44.00. The median estimate represents a +42.83% increase from the last price of 64.41.
The current consensus among 7 polled investment analysts is to Buy stock in Ligand Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.